I would say they chose Peros also due to his ability/experience to crowd fund a product. A great way to fund being like a CR but you get your product once completed as the first pre-sales. I have participated in crowd funding before & you actually feel like you were involved with helping launch! Be interesting to see his first project.
BG will obviously require the CR & I would definitely be in it as IMO the results with Ibuprofen were outstanding with many more pro's than con's not to mention the sports tapes etc.
Be great to see a quick way for FDA approval which I know there are ways of pushing through within or just over 12 months as long as you have plenty of research & data available to confirm.
If we go FDA approval on our own how would you think a relationship with Ibuprofen/Pfizer work? Will we be purchasing their product or will we be selling them our patch system/s or would it be a joint partnership?
- Forums
- ASX - By Stock
- WFL
- OBJ appoints Paul Peros as CEO of new device business
OBJ appoints Paul Peros as CEO of new device business, page-164
-
- There are more pages in this discussion • 139 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable